Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12953
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nash, J. | - |
dc.contributor.author | Stone, E. | - |
dc.contributor.author | Vinod, S. | - |
dc.contributor.author | Leong, T. | - |
dc.contributor.author | Dawkins, P. | - |
dc.contributor.author | Stirling, R. G. | - |
dc.contributor.author | Harden, S. | - |
dc.contributor.author | Bolton, A. | - |
dc.contributor.author | McWilliams, A. | - |
dc.contributor.author | O'Byrne, K. | - |
dc.contributor.author | Wright, G. M. | - |
dc.contributor.author | Brunelli, V. N. | - |
dc.contributor.author | Guan, T. | - |
dc.contributor.author | Philpot, S. | - |
dc.contributor.author | Navani, N. | - |
dc.contributor.author | Brims, F. | - |
dc.date.accessioned | 2024-09-02T05:56:56Z | - |
dc.date.available | 2024-09-02T05:56:56Z | - |
dc.date.issued | 2024 | - |
dc.identifier.issn | 13237799 (ISSN) | - |
dc.identifier.uri | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12953 | - |
dc.description.abstract | Background and Objective: Approximately 16,000 new cases of lung cancer are diagnosed each year in Australia and Aotearoa New Zealand, and it is the leading cause of cancer death in the region. Unwarranted variation in lung cancer care and outcomes has been described for many years, although clinical quality indicators to facilitate benchmarking across Australasia have not been established. The purpose of this study was to establish clinical quality indicators applicable to lung and other thoracic cancers across Australia and Aotearoa New Zealand. Methods: Following a literature review, a modified three round eDelphi consensus process was completed between October 2022 and June 2023. Participants included clinicians from all relevant disciplines, patient advocates, researchers and other stakeholders, with representatives from all Australian states and territories and Aotearoa New Zealand. Consensus was set at a threshold of 70%, with the first two rounds conducted as online surveys, and the final round held as a hybrid in person and virtual consensus meeting. Results: The literature review identified 422 international thoracic oncology indicators, and a total of 71 indicators were evaluated over the course of the Delphi consensus. Ultimately, 27 clinical quality indicators reached consensus, covering the continuum of thoracic oncologic care from diagnosis to first line treatment. Indicators benchmarking supportive care were poorly represented. Attendant numeric quality standards were developed to facilitate benchmarking. Conclusion: Twenty-seven clinical quality indicators relevant to thoracic oncology care in Australasia were developed. Real world implementation will now be explored utilizing a prospective dataset collected across Australia. � 2024 The Author(s). Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology. | - |
dc.publisher | John Wiley and Sons Inc | - |
dc.subject | best practice Delphi consensus process lung cancer mesothelioma | - |
dc.title | Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer | - |
dc.type | Journal Article | - |
dc.contributor.swslhdauthor | Vinod, Shalini K. | - |
dc.description.affiliates | Curtin Medical School, Curtin University, Perth, WA, Australia Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia Department of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital Sydney, Sydney, NSW, Australia School of Clinical Medicine, St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia South West Sydney Clinical Campuses, University of New South Wales, Sydney, NSW, Australia Cancer Therapy Centre, Liverpool Hospital, Sydney, NSW, Australia Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, VIC, Australia Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand Department of Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia Central Clinical School, Monash University, Melbourne, VIC, Australia University of Melbourne, Melbourne, VIC, Australia Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Department of Respiratory Medicine, Fiona Stanley Hospital, Perth, WA, Australia University of Western Australia, Perth, WA, Australia Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, QLD, Australia Queensland University of Technology, Brisbane, QLD, Australia Victorian Comprehensive Cancer Centre, Melbourne, VIC, Australia Department of Cardiothoracic Surgery, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, NSW, Australia Cancer Alliance Queensland, Brisbane, QLD, Australia Department of Thoracic Medicine, University College London Hospital, London, United Kingdom Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom National Centre for Asbestos Related Diseases, Institute for Respiratory Health, Perth, WA, Australia | - |
dc.identifier.doi | 10.1111/resp.14812 | - |
dc.identifier.department | Liverpool Hospital, Cancer Therapy Centre | - |
dc.type.studyortrial | Article | - |
dc.identifier.journaltitle | Respirology | - |
Appears in Collections: | Liverpool Hospital |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.